Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Nicholas Massanet"'
Publikováno v:
Journal of Oncology Pharmacy Practice. :107815522311719
Introduction Ibrutinib is a tyrosine kinase inhibitor approved for multiple B-cell malignancies, including Waldenstrom's macroglobulinemia in 2014. Although the drug portends favorable outcomes, it also bears a profile of side effects. Current litera